Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been ...

The mRNA-based supplier of vaccines profited from Covid-19 vaccine sales. As the years passed, Covid evolved. The weaker ...

The idea is that if you move your focus to attracting people, you’ll ultimately attract the companies: If you build it (the ...

The acquired portfolio includes Nicotinell, also known as Nicabate in Australia, Thrive in Canada and Habitrol in New Zealand and Canada.

BusinessWire India New Delhi [India] October 4 The Conclave on Advancing Oral Health in India - The Oral Health Collaborative ...

Another notable valuation metric for HLN is its P/B ratio of 2.28. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities.

EQUITY capital market bankers are rushing to finalise a fresh slate of deals in Europe, before the US presidential election ...

This summary covers recent developments in health news, from Humana's slumping Medicare plan enrollments impacting future ...

In a report released today, Guillaume Delmas from UBS maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target ...

Pharmaceutical giant Pfizer Inc. announced on Tuesday that it has reduced its stake in British consumer healthcare company ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

The latest health news highlights include Kailera Therapeutics' $400 million funding, potential CVS Health restructuring, ...